Urteste S.A. (URT.WA)
PLN 92.8
(-1.28%)
PLN 92.8
(-1.28%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 627 Thousand PLN | 5.03% |
| 2022 | 597 Thousand PLN | -15.92% |
| 2021 | 710 Thousand PLN | 0.0% |
| 2020 | - PLN | 0.0% |
| 2019 | - PLN | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 712 Thousand PLN | 13.56% |
| 2024 Q2 | 690 Thousand PLN | -3.09% |
| 2023 Q1 | 567 Thousand PLN | -5.03% |
| 2023 Q4 | 627 Thousand PLN | -16.73% |
| 2023 Q3 | 753 Thousand PLN | 10.57% |
| 2023 Q2 | 681 Thousand PLN | 20.11% |
| 2023 FY | 627 Thousand PLN | 5.03% |
| 2022 Q1 | - PLN | 0.0% |
| 2022 Q4 | 597 Thousand PLN | -4.78% |
| 2022 Q3 | 627 Thousand PLN | -4.42% |
| 2022 Q2 | 656 Thousand PLN | 0.0% |
| 2022 FY | 597 Thousand PLN | -15.92% |
| 2021 Q1 | - PLN | 0.0% |
| 2021 FY | 710 Thousand PLN | 0.0% |
| 2021 Q4 | - PLN | 0.0% |
| 2021 Q3 | - PLN | 0.0% |
| 2021 Q2 | - PLN | 0.0% |
| 2020 FY | - PLN | 0.0% |
| 2019 FY | - PLN | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bioceltix S.A. | 175.05 Thousand PLN | -258.169% |
| BIOTON S.A. | 68.69 Million PLN | 99.087% |
| Captor Therapeutics Spolka Akcyjna | 3.77 Million PLN | 83.404% |
| Mabion S.A. | 35.82 Million PLN | 98.25% |
| Molecure S.A. | 7.13 Million PLN | 91.218% |
| NanoGroup S.A. | - PLN | -Infinity% |
| Pharmena S.A. | 181 Thousand PLN | -246.409% |
| Poltreg S.A. | 8.19 Million PLN | 92.348% |
| Pure Biologics Spólka Akcyjna | 12.93 Million PLN | 95.154% |
| Ryvu Therapeutics S.A. | 906 Thousand PLN | 30.795% |
| Synthaverse S.A. | 70.04 Million PLN | 99.105% |